CHM Cannabis
Home > Boards > US Listed > Biotechs > Marinus Pharmaceuticals, Inc. (MRNS)

God help you Lion!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
jtf3 Member Profile
 
Followed By 8
Posts 1,530
Boards Moderated 0
Alias Born 03/27/13
160x600 placeholder
Marinus Pharmaceuticals to Present Ganaxolone Clinical Trial Data in CDKL5 Deficiency Disorder and PCDH19-Related Epilepsy at... GlobeNewswire Inc. - 11/19/2018 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/30/2018 4:03:36 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 10/29/2018 4:07:21 PM
Marinus Pharmaceuticals Provides Business Update and Third Quarter 2018 Financial Results GlobeNewswire Inc. - 10/29/2018 7:30:00 AM
Marinus Pharmaceuticals Names Dr. Rolando Gutíerrez-Esteinou as VP of Clinical Development and Pharmacovigilance GlobeNewswire Inc. - 10/10/2018 7:30:00 AM
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4) GlobeNewswire Inc. - 10/9/2018 4:48:55 PM
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. - 10/5/2018 4:00:00 PM
Marinus Completes Enrollment in its Magnolia Postpartum Depression Study GlobeNewswire Inc. - 9/25/2018 7:30:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/20/2018 4:08:33 PM
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. - 9/20/2018 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/5/2018 4:07:42 PM
Marinus Appoints Scott Braunstein, MD to its Board of Directors GlobeNewswire Inc. - 9/5/2018 7:30:00 AM
Marinus Pharmaceuticals to Present at the Baird Healthcare Conference GlobeNewswire Inc. - 8/30/2018 4:15:00 PM
Marinus Pharmaceuticals to Present at Wedbush/PacGrow Healthcare Conference GlobeNewswire Inc. - 8/7/2018 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/3/2018 6:08:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/2/2018 5:26:39 PM
Marinus Pharmaceuticals Provides Business Update and Second Quarter 2018 Financial Results GlobeNewswire Inc. - 8/2/2018 7:30:00 AM
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. - 7/30/2018 4:05:00 PM
Marinus Pharmaceuticals to Be Added to the Russell 2000 and Russell 3000 Index GlobeNewswire Inc. - 6/21/2018 7:30:00 AM
Marinus Pharmaceuticals Initiates Pivotal Phase 3 Trial in Children with CDKL5 Deficiency Disorder GlobeNewswire Inc. - 6/19/2018 7:30:00 AM
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4) GlobeNewswire Inc. - 6/15/2018 4:05:00 PM
Marinus Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 5/30/2018 7:30:00 AM
Marinus Pharmaceuticals to Present at the UBS Global Healthcare Conference GlobeNewswire Inc. - 5/14/2018 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/2/2018 9:09:56 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/2/2018 9:07:55 AM
jtf3   Friday, 02/09/18 05:38:35 PM
Re: Lion33 post# 471
Post # of 676 
God help you Lion!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist